BR9609332A - Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase - Google Patents

Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase

Info

Publication number
BR9609332A
BR9609332A BR9609332A BR9609332A BR9609332A BR 9609332 A BR9609332 A BR 9609332A BR 9609332 A BR9609332 A BR 9609332A BR 9609332 A BR9609332 A BR 9609332A BR 9609332 A BR9609332 A BR 9609332A
Authority
BR
Brazil
Prior art keywords
phase
biologically active
manufacture
active composition
cyclosporine
Prior art date
Application number
BR9609332A
Other languages
English (en)
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of BR9609332A publication Critical patent/BR9609332A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
BR9609332A 1995-07-06 1996-07-02 Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase BR9609332A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas
PCT/SE1996/000893 WO1997002042A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine

Publications (1)

Publication Number Publication Date
BR9609332A true BR9609332A (pt) 1999-05-25

Family

ID=20398887

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609332A BR9609332A (pt) 1995-07-06 1996-07-02 Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase

Country Status (12)

Country Link
EP (1) EP0873133B1 (pt)
JP (1) JPH11508592A (pt)
AT (1) ATE213951T1 (pt)
AU (1) AU6374596A (pt)
BR (1) BR9609332A (pt)
CA (1) CA2226219A1 (pt)
CZ (1) CZ1998A3 (pt)
DE (2) DE873133T1 (pt)
ES (1) ES2123477T3 (pt)
NO (1) NO980032L (pt)
SE (1) SE504582C2 (pt)
WO (1) WO1997002042A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
EP1039893B1 (en) 1997-12-10 2011-02-02 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
ES2289153T7 (es) 2001-11-08 2009-06-18 Atrium Medical Corporation Dispositivo intraluminal con un revestimiento que contiene un agente terapeutico.
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060088596A1 (en) 2004-09-28 2006-04-27 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
EP2626091B1 (en) 2006-11-06 2016-09-28 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
PT2079456E (pt) 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Composições farmacêuticas de ciclosporina
BRPI1012196B1 (pt) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited Composição compreendendo gotas de óleo
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
CN107106644B (zh) * 2014-11-07 2022-04-15 卓越治疗有限公司 包含环孢菌素的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE873133T1 (de) 1999-05-06
EP0873133B1 (en) 2002-03-06
WO1997002042A1 (en) 1997-01-23
NO980032L (no) 1998-03-03
DE69619700T2 (de) 2002-10-24
NO980032D0 (no) 1998-01-05
SE9502472L (sv) 1997-01-07
ES2123477T3 (es) 2002-08-01
ES2123477T1 (es) 1999-01-16
EP0873133A1 (en) 1998-10-28
SE9502472D0 (sv) 1995-07-06
SE504582C2 (sv) 1997-03-10
JPH11508592A (ja) 1999-07-27
CA2226219A1 (en) 1997-01-23
ATE213951T1 (de) 2002-03-15
AU6374596A (en) 1997-02-05
CZ1998A3 (cs) 1998-06-17
DE69619700D1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
BR9609332A (pt) Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
US3749773A (en) Gelled steroid ointment
BR9811058A (pt) Formulação auto-emulsificante para compostos lipofìlicos
BR9810866A (pt) Composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
IE870800L (en) Dual phase solvent carrier.
IE940583L (en) Topical antimicrobial pharmaceutical compositions
SE8305316D0 (sv) Topiskt applicerbart preparat
ES2105544T3 (es) Procedimiento para la preparacion de esferulas de principios activos.
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
BR9814756A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
CO4650228A1 (es) Enzima inmovilizada y su uso en el procesamiento de aceites trigloceridos
AR004691A1 (es) Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion
YU49113B (sh) Postupak za dobijanje klavulanat soli
IT1255076B (it) Microsfere biodegradabili ad uso farmaceutico e cosmetico
WO1997000671A3 (de) Zusammensetzung zur herstellung feindisperser systeme und verfahren zu ihrer herstellung
IE36563L (en) Triazolo benzodiazepines
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
EP0211434A3 (de) Rektale Dosierungsformen für Ceftriaxon
WO2000066100A3 (en) 2r,4s-hydroxyitraconazole isomers
SE9004076D0 (sv) Anvaendning av 10-acetyl-1,8,9-triacetoxi-antracen som antiinflammatoriskst medel vid framstaellning av farmaceutiska och kosmetiska kompositioner
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law